Serial 87249341
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 23 Aug 2024)
What this means for you
Registered since 24 Oct 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87249341
- Registration number
- 5315097
- Mark type
- Design / logo
- Filed
- 28 Nov 2016
- Published for opposition
- 08 Aug 2017
- Registered
- 24 Oct 2017
- Attorney of record
- Max Moskowitz
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of diabetes
Owner
- Boehringer Ingelheim International GmbH, Ingelheim, DE
- Boehringer Ingelheim International GmbH, Ingelheim, DE
- Boehringer Ingelheim International GmbH, Ingelheim, DE
Prosecution history
- 23 Aug 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Aug 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 12 Feb 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 12 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Aug 2023 — TEAS SECTION 8 & 15 RECEIVED
- 24 Oct 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Oct 2017 — REGISTERED-PRINCIPAL REGISTER
- 08 Aug 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Aug 2017 — PUBLISHED FOR OPPOSITION
- 19 Jul 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jun 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jun 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Jun 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Jun 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED